Correlation Between Bristol Myers and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Qualigen Therapeutics, you can compare the effects of market volatilities on Bristol Myers and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Qualigen Therapeutics.
Diversification Opportunities for Bristol Myers and Qualigen Therapeutics
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bristol and Qualigen is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Qualigen Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.2 times more return on investment than Qualigen Therapeutics. However, Bristol Myers Squibb is 4.99 times less risky than Qualigen Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 6,047 in Bristol Myers Squibb on November 1, 2024 and sell it today you would lose (133.00) from holding Bristol Myers Squibb or give up 2.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Qualigen Therapeutics
Performance |
| Timeline |
| Bristol Myers Squibb |
| Qualigen Therapeutics |
Bristol Myers and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Qualigen Therapeutics
The main advantage of trading using opposite Bristol Myers and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |